Chinese medical journal

• Latest
• Best
• Search…

• Chinese medical journal · Sep 2024

  De novo patients with high-volume metastatic hormone-sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy: Network-analysis and systematic review.

  no abstract available

  expand abstract… or not…

• Chinese medical journal · Sep 2024

  Gut microbiome and serum metabolome as a biomarkers of clinical severity and prognosis in patients with traumatic brain injury.

  no abstract available

  expand abstract… or just mark as read…

• Chinese medical journal · Sep 2024

  Comparison of robot-assisted partial nephrectomy with KangDuo surgical system vs. the da Vinci Si system: Quality of life and medium-term oncological outcomes.

  no abstract available

  read on… mark as read…

• Chinese medical journal · Sep 2024

  Photodynamic therapy of lung cancer: the present and the future.

  no abstract available

  read more… mark as read…

• Chinese medical journal · Sep 2024

  Percutaneous coronary intervention vs . medical therapy in patients on dialysis with coronary artery disease in China.

  The available evidence regarding the benefits of percutaneous coronary intervention (PCI) on patients receiving dialysis with coronary artery disease (CAD) is limited and inconsistent. This study aimed to evaluate the association between PCI and clinical outcomes as compared with medical therapy alone in patients undergoing dialysis with CAD in China. ⋯ This study indicated that PCI in patients on dialysis with CAD was significantly associated with lower MACE and mortality when comparing with those with medical therapy alone, albeit with a slightly increased risk for bleeding events that did not reach statistical significance.

  explore further… or not…